Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  IMAC Holdings, Inc.    IMAC

IMAC HOLDINGS, INC.

(IMAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 0.46 USD in weekly data.
  • The close medium term support offers good timing for purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses

No significant weakness

Sector Hospitals, Clinics & Primary Care Services
1st jan.Capitalisation (M$)Investor Rating
IMAC HOLDINGS, INC.-50.67%9
-
AIER EYE HOSPITAL GROUP CO...84.71%34 667
FRESENIUS SE & CO. KGAA-28.94%23 418
RAMSAY HEALTH CARE LIMITED-9.27%10 619
IHH HEALTHCARE-9.32%10 512
TOPCHOICE MEDICAL CORPORATI..110.67%10 364
BANGKOK DUSIT MEDICAL SERVI..0.00%9 270
HAPVIDA PARTICIPAÇÕES E INV..0.77%8 567
GRUPO NOTREDAME INTERMÉDICA..-4.57%7 108
APOLLO HOSPITALS ENTERPRISE..53.41%4 196
PREMIER, INC.-10.88%4 114
1LIFE HEALTHCARE, INC.0.00%3 853
MOUWASAT MEDICAL SERVICES C..55.68%3 658
THE ENSIGN GROUP, INC.26.07%3 041
MEDICLINIC INTERNATIONAL PL..-30.86%2 725
PT MITRA KELUARGA KARYASEHA..-0.75%2 564
More Results
Financials (USD)
Sales 2020 14,0 M - -
Net income 2020 -7,50 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,07x
Yield 2020 -
Capitalization 8,76 M 8,76 M -
Capi. / Sales 2020 0,63x
Capi. / Sales 2021 0,49x
Nbr of Employees 120
Free-Float 61,0%
Upcoming event on IMAC HOLDINGS, INC.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes